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Abstract
Introduction: The emergence of hepatic injury in patients with human immunodeficiency virus infection during
highly active therapy presents a diagnostic dilemma. It may represent treatment side effects or autoimmune
disorders, such as autoimmune hepatitis, emerging during immune restoration.
Case presentation: We present the case of a 42-year-old African-American woman with human immunodeficiency
virus infection who presented to our emergency department with severe abdominal pain and was found to have
autoimmune hepatitis. A review of the literature revealed 12 reported cases of autoimmune hepatitis in adults with
human immunodeficiency virus infection, only three of whom were diagnosed after highly active anti-retroviral
treatment was initiated. All four cases (including our patient) were women, and one had a history of other
autoimmune disorders. In our patient (the one patient case we are reporting), a liver biopsy revealed interface
hepatitis, necrosis with lymphocytes and plasma cell infiltrates and variable degrees of fibrosis. All four cases
required treatment with corticosteroids and/or other immune modulating agents and responded well.
Conclusion: Our review suggests that autoimmune hepatitis is a rare disorder which usually develops in women
about six to eight months after commencing highly active anti-retroviral treatment during the recovery of CD4
lymphocytes. It represents either re-emergence of a pre-existing condition that was unrecognized or a de novo
manifestation during immune reconstitution.
Introduction
Impaired immunity in individuals with human immuno-
deficiency virus (HIV) infection affects the defense
mechanisms against pathogens and alters the regulation
of autoimmunity [1]. This may lead to the emergence of
autoimmune disorders or modification of pre-existing
conditions. Several conditions may remit, such as sys-
temic lupus erythematosus (SLE), while others, such as
psoriasis, intensify. The development of liver disease
during highly active anti-retroviral treatment (HAART)
in patients with HIV infection without evidence of co-
infection with hepatitis viruses poses a diagnostic
dilemma. This may be due to treatment side effects or
to the emergence of autoimmune disorders during
immune restoration.
Autoimmune hepatitis (AIH) is rare in patients with
HIV infection. Additionally, hepatic involvement is unu-
sual in other common autoimmune disorders. We pre-
sent the case of a patient with AIH and SLE emerging
de novo during HAART and review all previously
reported cases of AIH in patients with HIV infection
who are undergoing HAART.
Case presentation
A 42-year-old African-American woman who had been
diagnosed with HIV infection in 1989 acquired by het-
erosexual contact had a fluctuating CD4 count and a
viral load secondary to non-adherence. In March 2009,
she was extensively counseled on adherence to treatment
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tabine/tenofovir and etravirine. She became more com-
pliant with treatment, and her clinical parameters
improved. Before March 2009, her CD4 had been 157
cells/mm
3 and her viral load had been 120,000 copies/
mL. One month after treatment adjustment, her CD4
went up to 232 cells/mm
3 and her viral load was unde-
tectable. There was no personal or family history of auto-
immune disease.
Six months after treatment adjustment she started to
experience gradual right upper quadrant pain associated
with intermittent night sweats. Her pain increased in
intensity and became intractable. A computed tomo-
graphic scan of her abdomen was unremarkable. She was
seen in the office with fever and tachycardia and was hos-
pitalized because of possible sepsis and acute abdomen.
Her physical examination revealed that she was febrile
(body temperature 102.1°F), tachycardic (130 beats/min)
and hypoxic (O
2 saturation 84% on room air). Her chest
examination revealed fine bibasilar crackles. Her abdom-
inal examination demonstrated diffuse abdominal ten-
derness with rebound that was most prominent in the
right upper quadrant.
A hepatobiliary iminodiacetic acid scan showed patent
biliary ducts with a normal gallbladder ejection fraction.
Computed tomography of the chest showed pericardial
effusion that was confirmed by a transthoracic
echocardiogram.
On day 3 of her hospitalization, she underwent a peri-
cardial window, a pericardial biopsy and a laparoscopy
with liver biopsy. The laparoscopy revealed a grossly
abnormal liver (Figure 1). The liver biopsy demonstrated
a dense portal lymphoplasmacytic infiltrate with multifo-
cal zones of hepatocellular centrilobular necrosis
consistent with AIH (Figure 2). Histological staining for
fungi and mycobacterium were negative.
Pertinent laboratory findin g si nt h i sp a t i e n ti n c l u d e d
alanine aminotransferase 1526 U/L, aspartate amino-
transferase 777 U/L, international normalized ratio, 1.53;
albumin level, 2.7 g/dL; anti-nuclear antibody (ANA)
titer, 1:1280; negative anti-smooth muscle antibody;
negative anti-cardiolipin and anti-ribosomal antibodies;
anti-double-stranded DNA (anti-dsDNA) titer, 1:160;
and immunoglobulin G level, 4600 mg/dL. Her antibo-
dies to hepatitis viruses A, B and C and hepatitis B sur-
face antigen were negative.
Given her clinical picture, her positive laboratory test
for ANA and anti-dsDNA and the histopathology of her
liver biopsy, a diagnosis of SLE with AIH was made.
Her calculated AIH score was 19 (> 15 is considered a
definite diagnosis according to the International
Autoimmune Hepatitis Group criteria).
The patient was initiated on high-dose steroid therapy
(40 mg every 12 hours). By the next day, her abdominal
pain had improved, and she was discharged from the
hospital on a tapering dose of steroids.
One year after her hospitalization the patient
remained in remission, with normal liver function and
suppressed HIV viral load. Her steroid therapy was
tapered off and stopped completely two months after
being discharged from the hospital.
Figure 1 Laparoscopic image of the liver showing diffuse
whitish-gray plaque without nodularity or cirrhosis.
Figure 2 Liver biopsy (hematoxylin and eosin stain) showing
dense portal lymphoplasmacytic infiltrate and centrilobular
hepatocellular necrosis caused by an acute chronic
inflammatory infiltrate suggestive of autoimmune hepatitis.
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Our review of the literature revealed 12 cases of autoim-
mune hepatitis in patients with HIV infection [2-8].
Three had co-infections with hepatitis C virus and were
receiving interferon therapy [6-8] and six more had AIH
before starting HAART and one pediatric patient’sd a t a
were missing. Only three patients developed AIH after
starting HAART, similar to our patient. The clinical
characteristics of the reviewed cases and our case are
shown in Table 1. All patients who received HAART
prior to AIH had a significant rise in CD4 count and
undetectable HIV RNA before AIH was diagnosed. Two
patients had other concomitant autoimmune diseases,
one with Grave’s disease and the other with diffuse infil-
trative lymphocytic syndrome. This review illustrates
that AIH in patients with HIV infection on HAART is
rare. It has been encountered in women who had signif-
icant elevations in CD4 count, suggesting the emergence
of AIH during immune restoration. It presented insi-
diously with non-specific manifestations. The diagnosis
is usually based on AIH score, the absence of other con-
ditions and characteristic histopathological findings.
In patients who develop liver function abnormalities
while receiving HAART, it is important to exclude
drug-induced liver disease. In our patient, the pathogno-
monic findings on the liver biopsy and the fact that she
had been taking these medications long before she
developed symptoms indicate that a drug reaction was
not likely.
The prognosis associated with AIH in patients with
HIV infection appears to be variable based on a review
of 11 out of the 12 reported cases (one reported case’s
data were missing) of AIH in patients with HIV infec-
tion. Two patients died while receiving interferon ther-
apy for hepatitis C virus that triggered fulminant AIH,
and one died as a result of severe Pneumocystis jiroveci
pneumonia while receiving high-dose steroids for the
treatment of AIH.
Our patient had evidence of SLE in addition to AIH.
Whether AIH is a manifestation of SLE or is unrelated
is unclear. Liver involvement associated with AIH is
relatively rare, ranging from 1.2% to 2% in patients with
SLE who do not have HIV infection [9]. To date, it has
not been reported simultaneously with SLE in patients
with HIV infection.
The precise mechanism causing the emergence or
unmasking of autoimmune conditions in patients who
are HIV-positive who commence anti-retroviral therapy
is complex and involves multiple cytokines and lympho-
cyte subsets [10-14]. Th17 cells have recently been
implicated in association with chronic autoimmunity
phenomena and especially in patients with HIV infec-
tion and primates with simian immunodeficiency virus
[10]. An additional subset of CD4
+ regulatory T cells
(Treg) has been described. It constitutively expresses
CD25 and the transcription factor FoxP3 and has regu-
latory functions [1]. Although the levels of Treg in
patients who are HIV-positive with autoimmune mani-
festations have not been reported, it seems plausible to
propose that preferential depletion of Treg in some indi-
viduals could account for the increased autoimmune
phenomena in some patients with acquired immunodefi-
ciency syndrome [15-18].
Conclusion
The present case report and review of the literature
describes a rare complication of immune restoration in
patients with HIV infection in the era of HAART.
Recognizing AIH in the context of immune reconstitu-
tion and initiating appropriate therapy can be lifesaving.
Treatment of these patients appears to be similar to that
of patients without HIV infection.
Table 1 Characteristics of 11 reported patients with concomitant HIV and AIH
a
Case reports Patient age (years)/gender Onset CD4
b/CD4
c VL
b/VL
c AIH score Outcome Other AI diseases ART
German et al. [2] 38
d/man Chronic 216/384 81,000/< 50 Probable Excellent Vetilligo Yes
Coriat and Podevin [7] 48/woman Acute 250 Undetectable Probable Died None Yes
Puius et al. [3] 29/man Chronic 259/174 7122/27,732 Probable Excellent None Yes
45
d/woman Chronic 253/297 8687/< 50 Probable Excellent DILS Yes
65/woman Acute 200/922 Undetectable/< 75 Definite Excellent None Yes
O’Leary et al. [4] 44
d/woman Chronic 269/526 4927/< 50 Definite Excellent Grave’s disease Yes
Wan et al. [5] 56/man Chronic 331/NA 232,734/NA Probable Died None
54/man Chronic 357/213 5104/NA Probable Probable Cirrhosis Yes
55/woman Chronic 174/NA < 50/NA Probable Probable Poor Yes
49/woman Acute 286/NA 69,318/NA Definite Definite Died Yes
Our patient 42
d/woman Acute 157/232 120,000/< 50 Definite Excellent SLE Yes
aTwo patients are not included because of lack of complete clinical data. HIV = human immunodeficiency virus; AIH = autoimmune hepatitis; AI, autoimmune;
ART = antiretroviral treatment; VL = viral load; DILS = diffuse infiltrative lymphocytic syndrome; SLE = systemic lupus erythematosus;
bprior to initiating highly
active antiretroviral treatment (HAART);
cafter initiating HAART;
dpatients with significant viral suppression on HAART who developed AIH.
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Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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